I know that diabetes can take a real toll on your body, but I didn't know that it includes your eyes. How are they affected ...

Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults, affecting more than 130 million people ...

Researchers have identified subtle, early-stage retinal alterations in type 2 diabetes using texture-based optical coherence tomography (OCT) ...

Optogenetics offers mutation-independent vision restoration for IRDs, with promising early-phase results in retinitis ...

Background/Aims Diabetic retinopathy (DR) is a major ocular complication of diabetes mellitus. While artificial intelligence ...

Intended to Maximize Stakeholder Value Through Structured Process -- Validated SCS Microinjector® Delivery Platform Anchored by Commercial ...

This article is part of “Innovations In: Type 1 Diabetes”, an editorially independent special report that was produced with financial support from Vertex. Sterling Glass had many health problems as a ...

Hypoglycemia is linked to an increased risk for and progression of diabetic retinopathy, according to new research presented at The Retina Society (TRS) Annual Meeting 2025. Severe hypoglycemia is ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR. (HealthDay News) — For individuals with type 2 diabetes (T2D), ...

A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...

Some reassuring news for patients taking GLP-1 receptor agonists: Concerns that the drugs may cause retinopathy may be overblown. A new analysis of nearly 160,000 people with diabetes taking four ...

LONG BEACH, Calif. -- Two different ocular implants eluting an endothelin antagonist showed early promise for slowing diabetic eye disease, according to two small studies reported here. In a ...